ILK and squamous cell carcinoma: In this study, we employed VS, based on the ILK protein structure, to find out two potential antiesophageal squamous cell carcinoma drugs, which are nilotinib and teniposide, and verified the binding ability of ILK protein with two compounds by surface plasmon resonance (SPR).